Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris602 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild66 AstraZeneca64 Institut National de la Santé Et de la Recherche Médicale, France63
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Paris

2821 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Université Paris Cité
Not applicable
1,500
Paris
2026-01-01
Recruiting
AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis
NCT07644715Arrhythmia, Long QT Syndrome, Immune Checkpoint Inhibitor-Related Myocarditis
Groupe Hospitalier Pitie-Salpetriere
Observational
127,000
Paris
2026-01-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2
50
Paris
2026-01-01
Not yet open
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
NCT07160959Chronic Kidney Disease (Stages 4 and 5), Mild Cognitive Impairment (MCI)
Biogem s.c.ar.l.
Not applicable
124
Paris
2026-01-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
70
Paris
2026-01
Not yet open
Antibiotics Distribution Study in Peripheral Compartments: Contribution of Microdialysis
NCT07327502Children in Cardiac Intensive Care Requiring Surgery for Congenital Heart Disease
Assistance Publique - Hôpitaux de Paris
Not applicable
10
Paris
2026-01
Not yet open
Awake Prone Positioning for Severe Acute Chest Syndrome
NCT06698120Acute Chest Syndrome, Sickle Cell Anemia
Assistance Publique - Hôpitaux de Paris
Not applicable
15
Paris
2026-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
120
Paris
2026-01
Not yet open
Centre Hospitalier Universitaire de Besancon
Phase 2
98
Besançon, Dijon, Marseille, Paris
2026-01
Recruiting
Sanofi
Phase 2
144
Lille, Nantes, Paris, Rouen
2025-12-29
Recruiting
Centre Hospitalier St Anne
Not applicable
215
Paris
2025-12-29
Recruiting
AstraZeneca
Phase 3
1,100
Amiens, Avignon, Nîmes, Paris, Pau, Pierre-Bénite, Plerin SUR MER, Reims
2025-12-29
Recruiting
Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
NCT07157670Cardiotoxicity, DPP3, HSCT, Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris
Observational
400
Paris
2025-12-25
Recruiting
AEF0217 in Participants With Down Syndrome
NCT07334912Down Syndrome (Trisomy 21)
Aelis Farma
Phase 2
188
Bordeaux, Lyon, Montpellier, Paris, Saint-Etienne
2025-12-22
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
75
Besançon, Dijon, Grenoble, Lyon, Montpellier, Paris, Rennes, Tours
2025-12-22
Recruiting
Tyra Biosciences, Inc
Phase 2
285
Paris
2025-12-22
Not yet open
Mechanisms of Fecal Incontinence in Wolfram Syndrome
NCT07313085Wolfram Syndrome, Fecal Incontinence
Hôpital Necker-Enfants Malades
Observational
20
Paris
2025-12-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
33
Paris
2025-12-19
Recruiting
Heart Failure Management for Patient With CIED Remotely Monitored
NCT07247032Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure With Reduced Ejection Fraction (HFrEF)
Implicity
Not applicable
1,132
Paris
2025-12-19
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Bordeaux, Clermont-Ferrand, Lille, Lyon, Nîmes, Paris, Rennes, Villejuif
2025-12-19
Recruiting
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block
Boston Scientific Corporation
Observational
140
Lille, Paris
2025-12-19
Recruiting
Post-market Clinical Follow-up Study of NEMOST V2
NCT07403084Scoliosis Neuromuscular, Scoliosis Idiopathic, Consent Forms
EUROS
Not applicable
140
Nice, Bordeaux, Lyon, Paris
2025-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Bordeaux, Toulouse, Nantes, Lyon, Bobigny, Paris
2025-12-18
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
100
Paris
2025-12-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
41
Lyon, Paris, Rennes, Toulouse
2025-12-16
Not yet open
University Hospital, Bordeaux
Not applicable
53
Montpellier, Palavas-les-Flots, Paris, Talence
2025-12-15
Recruiting
University Hospital, Angers
Not applicable
200
Angers, Le Mans, Nantes, Orléans, Paris, Pointe à Pitre, Rennes, Tours
2025-12-13
Recruiting
Angitia Incorporated Limited
Phase 2
80
Lyon, Paris
2025-12-12
Recruiting
Fondation Hôpital Saint-Joseph
Not applicable
100
Paris
2025-12-12
Recruiting
GlaxoSmithKline
Phase 3
1,250
Paris
2025-12-12
Recruiting
Ascendis Pharma A/S
Phase 3
186
Angers, Le Kremlin-Bicêtre, Montpellier, Paris, Toulouse
2025-12-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,000
Angers, Bordeaux, Brest, Lille, Lyon, Marseille, Paris, Strasbourg
2025-12-11
Recruiting
Pfizer
Phase 3
800
Villejuif, Brest, Dijon, Lille, Paris, Poitiers, Créteil
2025-12-11
Active, closed
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
NCT07181590Paroxysmal AF, Atrial Arrhythmia, Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Paris, Pessac, Toulouse
2025-12-11
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Angers, Bron, Nantes, Paris, Pessac, Vandœuvre-lès-Nancy
2025-12-11
Recruiting
AbbVie
Phase 2/3
490
Marseille, Brest, Lille, Montpellier, Paris
2025-12-10
Recruiting
ALX Oncology Inc.
Phase 2
120
Besançon, Bordeaux, Paris, Poitiers, Rennes
2025-12-10
Recruiting
AstraZeneca
Phase 2
230
Lyon, Montpellier, Nantes, Nîmes, Paris, Tours
2025-12-10
Active, closed
Asten Sante
Observational
60
Paris
2025-12-09
Active, closed
Boehringer Ingelheim
Phase 3
135
Bron, Marseille, Nantes, Paris, Toulouse
2025-12-09
Recruiting
Cystinosis and Mitochondrial Metabolism
NCT07319091Cystinosis, Native Kidney
Hospices Civils de Lyon
Not applicable
25
Bron, Lille, Lyon, Marseille, Montpellier, Paris, Vandœuvre-lès-Nancy
2025-12-08
Recruiting
Centre Leon Berard
Phase 3
132
Brest, Clermont-Ferrand, Lyon, Marseille, Paris, Poitiers
2025-12-08
Recruiting
Hoffmann-La Roche
Phase 2
160
Strasbourg, Marseille, Montpellier, Toulouse, Paris
2025-12-05
Recruiting
Prognosis of Early-onset Anorexia Nervosa
NCT07311356Anorexia Nervosa
Assistance Publique - Hôpitaux de Paris
Observational
140
Paris
2025-12-05
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Limoges, Paris
2025-12-04
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Avignon, Le Mans, Lille, Marseille, Paris, Rouen, Saint-Herblain, Villejuif
2025-12-03
Recruiting
Ventus Therapeutics U.S., Inc.
Phase 2
24
Paris, Toulouse
2025-12-03
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2/3
120
Paris
2025-12-03
Not yet open
Transfusion Exchanges and Cognition in Sickle Cell Disease
NCT07168447Drepanocytosis, Chronic Neurological Deficiency
Centre Hospitalier St Anne
Observational
85
Bobigny, Créteil, Le Kremlin-Bicêtre, Paris, Saint-Denis
2025-12-03
Recruiting
Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber
NCT07544563Epilepsy, Anxiety, Depression Anxiety Disorder
Centre Hospitalier St Anne
Observational
320
Paris
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 3
650
Toulouse, Villeurbanne, Lille, Limoges, Montpellier, Paris, Strasbourg
2025-12-02
Recruiting
Dapagliflozin for Cardio-renal Protection After ICU Discharge
NCT07025629Heart Failure and Chronic Kidney Disease Post-ICU
DrugsFarxiga·Dapagliflozin
Assistance Publique - Hôpitaux de Paris
Phase 3
600
Paris
2025-12-02
Recruiting
Sanofi
Phase 2
37
Marseille, Paris
2025-12-02
Active, closed
Institut Cancerologie de l'Ouest
Observational
22,000
Lille, Lyon, Paris, Saint-Herblain
2025-12-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
125
Paris
2025-12-01
Not yet open
University Hospital, Toulouse
Not applicable
178
Bordeaux, Lille, Marseille, Montpellier, Paris, Quint-Fonsegrives, Toulouse
2025-12-01
Recruiting
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Not applicable
80
Paris
2025-12-01
Not yet open
Impact of Ambulatory Management for Primary Spontaneous Pneumothorax in the Emergency Department on Quality of Life
NCT06471608Primary Spontaneous Pneumothorax, Quality of Life, Ambulatory Care, Chest Tube
University Hospital, Strasbourg, France
Not applicable
386
Besançon, Bordeaux, La Tronche, Paris, Poitiers, Strasbourg
2025-12-01
Recruiting
A Phase 2 Study of CRD-4730 in CPVT
NCT06658899Catecholaminergic Polymorphic Ventricular Tachycardia
DrugCRD-4730
Cardurion Pharmaceuticals, Inc.
Phase 2
12
Bron, Paris, Saint-Herblain
2025-12-01
Recruiting
Prof. Dr. Martin Wabitsch
Observational
70
Paris
2025-12-01
Not yet open
PPV-06 Vaccine in Inflammatory Knee Osteoarthritis
NCT06605963Osteoarthritis, Knee
Peptinov SAS
Phase 2
204
Paris
2025-12
Not yet open
Advesya SAS
Phase 1/2
143
Besançon, Paris
2025-12
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
76
Paris
2025-11-28
Recruiting
Amgen
Phase 3
750
Bordeaux, Caen, Clermont-Ferrand, Le Mans, Lyon, Nice, Paris, Strasbourg
2025-11-28
Recruiting
Hoffmann-La Roche
Phase 3
250
Nantes, Lyon, Montauban, Paris, Poitiers, Strasbourg
2025-11-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
60
Paris
2025-11-26
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Marseille, Paris, Strasbourg, Toulouse
2025-11-26
Recruiting
SAb Biotherapeutics, Inc.
Phase 2
159
Paris
2025-11-25
Recruiting
Momelotinib in VEXAS Syndrome
NCT07098936VEXAS Syndome, Myelo Dysplastic Syndrome
Groupe Francophone des Myelodysplasies
Phase 2
57
Angers, Clermont-Ferrand, Lille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes
2025-11-25
Recruiting
French Cardiology Society
Observational
314
Paris
2025-11-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2025-11-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
35
Paris
2025-11-25
Recruiting
Institut de Recherches Internationales Servier
Phase 1/2
20
Marseille, Paris
2025-11-24
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Bordeaux, Dijon, Limoges, Marseille, Nantes, Nice, Paris
2025-11-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
400
Paris
2025-11-24
Recruiting
Hospital General Universitario Gregorio Marañon
Phase 3
103
Paris
2025-11-20
Recruiting
Pfizer
Phase 2
165
Paris, Rouen, Toulouse
2025-11-20
Active, closed
Bayer
Phase 2
60
Brest, Toulouse, Paris
2025-11-19
Active, closed
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Chambray-lès-Tours, Clichy, Marseille, Nantes, Nice, Paris, Pessac, Toulouse
2025-11-19
Active, closed
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
NCT07161037Autosomal Dominant Polycystic Kidney Disease (ADPKD)
DrugVX-407
Vertex Pharmaceuticals Incorporated
Phase 2
26
Brest, Paris, Tours
2025-11-19
Recruiting
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
NCT07077304Myocarditis, ANCA Associated Vasculitis, Pericarditis, Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris
Observational
5,000
Paris
2025-11-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
2,920
Paris, Fontainebleau, Montereau-Fault-Yonne, Nemours, Rambouillet, Saint-Denis
2025-11-19
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 2
144
Besançon, Pessac, Nantes, Marseille, Paris, Lyon, Poitiers
2025-11-18
Recruiting
Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)
NCT07239791Role of the Noradrenergic System in the Regulation of Learning Dynamics, No Disease or Condition is Being Studied
DrugAtomoxetine
Centre Hospitalier St Anne
Not applicable
160
Paris
2025-11-18
Recruiting
Summit Therapeutics
Phase 3
600
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice, Paris
2025-11-18
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
162
Dijon, Grenoble, Paris, Suresnes, Toulon, Villejuif
2025-11-17
By invitation
Materialise
Observational
200
Paris
2025-11-17
Recruiting
University Hospital, Angers
Not applicable
20
Angers, Brest, Le Kremlin-Bicêtre, Montpellier, Nantes, Paris, Rennes, Tours
2025-11-16
Recruiting
UNICANCER
Phase 2/3
196
Bordeaux, Clichy, Dijon, Marseille, Montpellier, Nantes, Paris, Poitiers
2025-11-14
Recruiting
University Hospital, Bordeaux
Not applicable
100
Bordeaux, Montpellier, Paris
2025-11-13
Recruiting
Incyte Corporation
Phase 3
250
Argenteuil, Bordeaux, Créteil, Lyon, Nantes, Nice, Paris, Reims
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Amiens Cedex1, Bordeaux, Bron, Limoges, Montpellier, Paris, Saint-Herblain, Strasbourg
2025-11-12
Recruiting
University Hospital, Bordeaux
Not applicable
60
Amiens, Bordeaux, Limoges, Paris, Rouen
2025-11-10
Recruiting
Nantes University Hospital
Phase 3
478
Chambray-lès-Tours, Lille, Lyon, Marseille, Metz, Montpellier, Nantes, Paris
2025-11-07
Recruiting
University Hospital, Lille
Not applicable
616
Bobigny, Levallois-Perret, Lille, Limoges, Nantes, Paris, Pierre-Bénite, Poitiers
2025-11-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,288
Paris
2025-11-06
Recruiting
Pfizer
Phase 1
294
Villejuif, Paris
2025-11-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
300
Clichy, Nantes, Paris
2025-11-06
Recruiting
AstraZeneca
Phase 2
435
Brest, Créteil, Marseille, Montpellier, Paris, Pessac, Strasbourg, Toulouse
2025-11-06
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
65
Nice, Nantes, Pierre-Bénite, Dijon, Lille, Marseille, Montpellier, Paris
2025-11-06
Recruiting
TBF Genie Tissulaire
Phase 3
96
Clermont-Ferrand, La Tronche, Nantes, Paris, Pierre-Bénite, Rouen, Strasbourg, Toulouse
2025-11-06
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
Centre Leon Berard
Phase 1/2
70
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Paris, Toulouse
2025-11-04
Recruiting
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NCT06735560Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Neuroendocrine Tumors
Nantes University Hospital
Not applicable
60
Nantes, Paris
2025-11-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
24
Paris
2025-11-03
Recruiting
Novartis Pharmaceuticals
Phase 2
30
Bordeaux, Bron, Le Kremlin-Bicêtre, Lille, Paris
2025-11-03
Recruiting
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
NCT07010250ANCA Associated Vasculitis, Extramembranous Glomerulopathy, Nephrotic Syndrome, Minimal Change, Interstitial Nephritis
Assistance Publique - Hôpitaux de Paris
Observational
146
Paris
2025-11-03
By invitation
Worldwide Assessment of Deceased Donor Kidney Utilization
NCT07341516Kidney Failure, Kidney Transplant, Deceased Donor Kidney Transplant
Paris Translational Research Center for Organ Transplantation
Observational
300,000
Paris
2025-11-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
40
Paris
2025-11-01
Not yet open
French Cardiology Society
Not applicable
37
Paris
2025-11-01
Not yet open
Fondation Hôpital Saint-Joseph
Not applicable
2,052
Boussy-Saint-Antoine, Lyon, Nantes, Paris, Saint-Cloud, Saint-Etienne, Suresnes, Toulouse
2025-11
Not yet open
Efficacy of Prostatic Arteries Embolization Using SQUIDPERI
NCT07255508Benign Prostate Hypertrophy(BPH)
Assistance Publique - Hôpitaux de Paris
Observational
100
Marseille, Montpellier, Paris, Strasbourg
2025-11
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
230
Corbeil-Essonnes, Lyon, Montpellier, Paris
2025-11
Recruiting
Eli Lilly and Company
Phase 3
1,205
Angers, Chambray-lès-Tours, Lomme, Nice, Paris, Rennes
2025-10-31
Recruiting
French Cardiology Society
Observational
1,000
Lille, Paris
2025-10-30
Recruiting
Laboratoires Thea
Observational
30
Paris
2025-10-30
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
60
Angers, Paris
2025-10-30
Recruiting
AstraZeneca
Phase 3
100
Clermont-Ferrand, La Roche-sur-Yon, Montpellier, Paris, Pierre-Bénite
2025-10-30
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
480
Paris
2025-10-28
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
348
Bordeaux, Bron, Garches, Le Kremlin-Bicêtre, Lille, Marseille, Nancy, Paris
2025-10-28
Recruiting
Endowave Ltd.
Not applicable
43
Paris
2025-10-24
Recruiting
Hoffmann-La Roche
Phase 3
600
Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris
2025-10-24
Recruiting
Septodont
Observational
275
Lyon, Nantes, Paris, Rennes
2025-10-23
Recruiting
Monitoring of Anti-TFPI in Hemophilia
NCT07101926Hemophilia, Rebalancing Agents, Prophylaxis
DrugBlood sampling
Hospices Civils de Lyon
Observational
11
Bron, Paris
2025-10-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
2,860
Paris
2025-10-22
Recruiting
Eli Lilly and Company
Phase 2
531
Aix-en-Provence, Brest, Cholet, Le Chesnay, Le Kremlin-Bicêtre, Montfermeil, Paris, Pessac
2025-10-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
70
Angers, Bordeaux, Dijon, Lyon, Montpellier, Paris, Rouen, Strasbourg
2025-10-21
Recruiting
Institut Claudius Regaud
Not applicable
130
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-21
Recruiting
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
NCT07407465Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma
DrugsTrastuzumab deruxtecan·Capecitabine·Bevacizumab
Gruppo Oncologico del Nord-Ovest
Phase 2
42
Lyon, Marseille, Paris, Reims, St-Malo
2025-10-20
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
544
Paris
2025-10-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
830
Paris
2025-10-20
Recruiting
Extended Prone Positioning for Intubated ARDS
NCT07126964Acute Respiratory Distress Syndrome
Assistance Publique - Hôpitaux de Paris
Not applicable
800
Paris
2025-10-18
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Besançon, Bobigny, Bordeaux, Créteil, Nice, Paris, Poitiers, Tours
2025-10-17
Recruiting
Institut Pasteur
Observational
8
Paris
2025-10-16
Recruiting
Pharvaris Netherlands B.V.
Phase 3
48
Grenoble, Lille, Paris
2025-10-16
Recruiting
Efficacy of Dexmedetomidine Versus Midazolam Sedation on Extubation Time in Mechanically Ventilated Preterm Infants
NCT06878703PreTerm Neonate, Sedation for Invasive Mechanical Ventilation, Very Preterm Neonates With Sedation for Invasive Mechanical Ventilation
DrugsMidazolam·Dexmedetomidine
Assistance Publique - Hôpitaux de Paris
Phase 3
380
Paris
2025-10-16
Recruiting
Imagine Institute
Observational
3,100
Paris
2025-10-16
Not yet open
Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)
NCT07081464Ondine Syndrome (Congenital Central Hypoventilation Syndrome)
Assistance Publique - Hôpitaux de Paris
Observational
25
Paris
2025-10-15
Recruiting
Novartis Pharmaceuticals
Phase 1/2
188
Bordeaux, Paris
2025-10-15
Recruiting
Institut Claudius Regaud
Phase 4
210
Angers, Dijon, Lille, Marseille, Nîmes, Paris, Rennes, Strasbourg
2025-10-15
Recruiting
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
NCT07237009Neurocognitive Disorders, Mild, Cognitive Impairment, Mild, Depression Mild, Apathy
KompanionCare SAS
Observational
80
Angers, Limoges, Nice, Paris, Tours
2025-10-14
Recruiting
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Observational
60
Paris
2025-10-13
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
1,102
Hendaye, Hyères, La Force, Marseille, Paris
2025-10-13
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
100
Paris
2025-10-13
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 2
60
Marseille, Paris
2025-10-13
Not yet open
Evaluation of Dalia Solution For Depressed Patient
NCT07211984Depression Chronic, Depressed, Depressed Mood, Depression and Quality of Life
Dalia Care
Not applicable
644
Paris
2025-10-10
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Angers, Bron, Dijon, Montpellier, Paris, Toulouse, Tours
2025-10-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
675
Marseille, Caen, Vandœuvre-lès-Nancy, Pau, Chambéry, Amiens, Paris
2025-10-08
Recruiting
Bristol-Myers Squibb
Observational
223
Bordeaux, Strasbourg, Paris
2025-10-08
Recruiting
SparingVision
Phase 1/2
27
Paris
2025-10-08
Active, closed
Embobio Medical
Not applicable
45
Paris
2025-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
424
Nice, Clermont-Ferrand, Marseille, Montpellier, Paris
2025-10-08
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Montpellier, Paris, Saint-Herblain
2025-10-06
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
60
Le Kremlin-Bicêtre, Paris
2025-10-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2
21
Paris
2025-10-01
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsRuxolitinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2025-10-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
160
Le Plessis-Robinson, Paris
2025-10-01
By invitation
Astria Therapeutics, Inc.
Phase 3
145
Paris
2025-10-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
40
Paris
2025-10-01
Active, closed
Hospices Civils de Lyon
Phase 2
27
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-01
Not yet open
Biomarkers in Systemic Histiocytosis
NCT07157683Systemic Histiocytosis (Disorder)
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsDasatinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2025-10-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
15
Paris
2025-10-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 1
20
Limoges, Nancy, Paris, Rouen
2025-10-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2025-10
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
60
Bobigny, Boulogne-Billancourt, Clichy, Créteil, Le Kremlin-Bicêtre, Paris
2025-10
Not yet open
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Not applicable
32
Paris
2025-10
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2025-10
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
750
Paris
2025-10
Recruiting
Clinical Course Of Disease In Participants With FA-CM
NCT06865482Friedreich Ataxia, Cardiomyopathy
Lexeo Therapeutics
Observational
65
Paris
2025-09-30
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
175
Paris
2025-09-30
Recruiting
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
200
Bordeaux, Marseille, Paris, Toulouse
2025-09-30
Recruiting
Centre Hospitalier St Anne
Observational
8
Paris
2025-09-29
Recruiting
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NCT06960902Familial Hypercholesterolemias, Atherosclerotic Cardiovascular Disease (ASCVD)
Nantes University Hospital
Not applicable
600
Dijon, Lille, Lyon, Marseille, Nantes, Paris, Rennes, Strasbourg
2025-09-25
Recruiting
Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care.
NCT07107685Osteoarticular Infections, Intensive Care Patients, Prosthetic Joint Infection
Assistance Publique - Hôpitaux de Paris
Observational
150
Paris
2025-09-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2025-09-23
Recruiting
Hospices Civils de Lyon
Observational
200
Bron, Le Plessis-Robinson, Marseille, Paris, Pessac, Toulouse
2025-09-23
Active, closed
Groupe Hospitalier Diaconesses Croix Saint-Simon
Not applicable
150
Paris
2025-09-22
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
845
Paris
2025-09-22
Recruiting
The Lymphoma Academic Research Organisation
Phase 2
60
Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Nancy, Paris, Pierre-Bénite
2025-09-22
Recruiting
Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty
NCT06982625Hip Arthroplasty, Total, Post Operative Pain, Acute, Nerve Block
Institut Mutualiste Montsouris
Not applicable
310
Paris
2025-09-22
Active, closed
Bristol-Myers Squibb
Phase 2
76
Dijon, Suresnes, Paris
2025-09-19
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Clermont-Ferrand, Limoges, Montpellier, Nice, Paris, Tours
2025-09-17
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Le Kremlin Bicétre Cedex, Lille, Marseille, Paris, Rennes, Toulouse, Tours, Vandœuvre-lès-Nancy
2025-09-17
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
60
Paris
2025-09-17
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Lille, Paris, Créteil, Bourdeaux, Nice
2025-09-16
Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
NCT07047144Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 3
DrugsApitegromab·Nusinersen·Risdiplam
Scholar Rock, Inc.
Phase 2
52
Paris
2025-09-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
50
Paris
2025-09-15
Recruiting
Tezspire Cardiac Events PASS
NCT06951867Cardiovascular Events, MACE
DrugTezepelumab
AstraZeneca
Observational
16,640
Paris
2025-09-15
Recruiting
Multimodal Cardiovascular and Hepatic Population Imaging
NCT06906042Healthy Volunteers, Imaging Evaluation
Institut National de la Santé Et de la Recherche Médicale, France
Observational
2,400
Paris
2025-09-15
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Angers, Bordeaux, Lille, Paris, Rennes, Strasbourg, Toulouse
2025-09-13
Recruiting
Archean Technologies
Not applicable
100
Lyon, Paris, Toulouse
2025-09-10
Recruiting
Evaluation of the Effect of Reiki on Pain After Lumbar Surgery
NCT07722117The Lumbar Spine Surgical Intervention, Arthrodesis, Severe Herniated Disc, Scoliosis
Clinique Bizet
Not applicable
60
Paris
2025-09-10
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Marseille, Paris, Quint-Fonsegrives, Saint-Grégoire, Villejuif
2025-09-10
Recruiting
Institut Pasteur
Observational
75
Paris
2025-09-10
Recruiting
Clinique Bizet
Not applicable
60
Paris
2025-09-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
205
Paris
2025-09-09
Recruiting
Bristol-Myers Squibb
Phase 2
182
La Tronche, Saint-Herblain, Vandœuvre-lès-Nancy, Bron, Paris
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Angers, Brest, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris
2025-09-08
Recruiting
Institut Curie
Observational
200
Paris
2025-09-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Auxerre, Bobigny, Bordeaux, Caen, Nîmes, Paris, Pau, Poitiers
2025-09-06
Recruiting
BeOne Medicines
Phase 3
500
Bordeaux, ClermontFerrand, Nantes, Paris, Rouen, Toulouse, Tours, VandoeuvrelesNancy
2025-09-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
30
Paris
2025-09-04
Recruiting
Hôpital NOVO
Not applicable
190
Aix-en-Provence, Brest, Caen, Dijon, Nantes, Paris, Pontoise, Tours
2025-09-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
140
Lyon, Montpellier, Paris, Reims, Strasbourg, Villejuif
2025-09-03
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
180
Paris
2025-09-03
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bordeaux, Brest, Dijon, Lille, Lyon, Paris, Pierre-Bénite, Saint-Herblain
2025-09-02
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Not yet open
Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma
NCT06933966Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Non Metastatic Disease
Centre Leon Berard
Phase 2
120
Lyon, Marseille, Paris
2025-09-01
Recruiting
Centre Hospitalier Universitaire de Liege
Not applicable
32
Paris
2025-09-01
Recruiting
Ustekinumab in BEhçet's Syndrome STudy
NCT07244614Behçet's Syndrome (BS)
Groupe français d'étude des Maladies Inflammatoires de loeil
Observational
208
Bordeaux, Créteil, Lyon, Melun, Paris, Rouen
2025-09-01
Not yet open
University Hospital, Rouen
Observational
16
Caen, Paris, Rouen
2025-09-01
Recruiting
Japet Medical Devices
Not applicable
102
Clermont-Ferrand, Paris
2025-09-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
650
Paris
2025-09-01
Not yet open
Paris Translational Research Center for Organ Transplantation
Observational
600
Paris
2025-09-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
50
Paris
2025-09-01
Not yet open
Hospices Civils de Lyon
Observational
268
Besançon, Bron, Clermont-Ferrand, Lille, Limoges, Nîmes, Paris, Saint-Etienne
2025-09-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2
5
Paris
2025-09-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
1,500
Paris
2025-09
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2025-09
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
162
Amiens, Besançon, Caen, La Roche-sur-Yon, Lille, Lyon, Paris, Pessac
2025-09
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2/3
526
Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Lyon, Marseille, Paris, Rouen, Toulouse
2025-09
Not yet open
Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
NCT07167186Inflammatory Bowel Disease (IBD), Crohn Disease, Ulcerative Colitis (Disorder)
Assistance Publique - Hôpitaux de Paris
Observational
240
Paris
2025-09
Recruiting
SiREX-Stent for the Treatment of SymptOmatic Lateral VEnous Sinus Stenosis
NCT06726928Treatment of Symptomatic Lateral Sinus Stenosis, Treatment of Pulsatile Tinnitus Due tu Sinus Stenosis
Acandis GmbH
Not applicable
78
Paris
2025-09
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
60
Avignon, Besançon, Levallois-Perret, Lyon, Paris, Pessac, Poitiers, Toulouse
2025-09
Not yet open
Video Analysis and Artificial Intelligence for the Analysis of Upper Limb Movement in Children
NCT07147478Clinical Examination of the Shoulder, Video-assisted Clinical Examination
Assistance Publique - Hôpitaux de Paris
Observational
150
Paris
2025-09
Not yet open
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
50
Paris
2025-09
Not yet open
Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
NCT07146334Rectal Cancer, Surgery Indication
Bordeaux Colorectal Institute
Observational
400
Besançon, Bordeaux, Le Kremlin-Bicêtre, Lyon, Paris, Rouen
2025-09
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
346
Lille, Marseille, Paris, Rouen, Suresnes, Villejuif
2025-09
Not yet open
Centre Hospitalier St Anne
Observational
84
Paris
2025-09
Recruiting
Central Hospital, Nancy, France
Not applicable
103
Bron, La Tronche, Montpellier, Nantes, Paris, Pessac, Rennes, Rouen
2025-08-29
Recruiting
Modeling Amyotrophic Lateral Sclerosis With Fibroblasts
NCT06450691Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris
Not applicable
110
Paris
2025-08-28
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Grenoble, Montpellier, Paris
2025-08-28
Recruiting
Prospective Evaluation of OptiThyDose
NCT06864351Thyroid Diseases, Congenital Hypothyroidism, Graves Disease
University Children's Hospital Basel
Not applicable
150
Paris
2025-08-28
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
130
Paris
2025-08-27
Recruiting
Basilea Pharmaceutica
Phase 3
234
Nantes, Paris, Rennes
2025-08-26
Recruiting
University of Minnesota
Observational
1,500
Lyon, Paris
2025-08-25
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Marseille, Paris, Bordeaux, Le Kremlin-Bicêtre, Nice, Strasbourg, Toulouse
2025-08-22
Recruiting
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
NCT07028112Iron Overload, Hemosiderosis, Liver Diseases, Hematopoietic Stem Cell Transplantation (HSCT)
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2025-08-20
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsPRL-02·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Bordeaux, Le Mans, Lille, Paris, Strasbourg
2025-08-19
Active, closed
Amgen
Phase 3
350
Créteil, Lyon, Marseille, Paris, Saint-Herblain, Toulon, Toulouse
2025-08-18
Recruiting
Institut Pasteur
Not applicable
80
Paris
2025-08-14
Recruiting
Sanofi
Phase 3
192
Créteil, Marseille, Paris, Toulouse
2025-08-12
Recruiting
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus
NCT06876467Hepatitis B Vaccination, Immune Response, T Cells
Assistance Publique - Hôpitaux de Paris
Observational
115
Paris
2025-08-11
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
6
Paris
2025-08-11
Active, closed
AstraZeneca
Phase 3
212
Amiens, Bois-Guillaume, Bordeaux, Lille, Paris
2025-08-07
Active, closed
Novartis Pharmaceuticals
Phase 2
97
Toulouse, Paris
2025-08-07
Recruiting
AstraZeneca
Phase 2
278
Avignon, Paris, Rennes, Saint-Herblain, Suresnes
2025-08-07
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 2
180
Toulouse, Lille, Paris, Villeurbanne, Bron, Strasbourg, Tours, Vandœuvre-lès-Nancy
2025-08-06
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT07114601Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms
Eli Lilly and Company
Phase 1
421
Paris, Saint-Herblain
2025-08-06
Recruiting
Sanofi
Phase 3
723
Bron, La Tronche, Lille, Paris, Pau, Strasbourg
2025-08-06
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
31
Paris, Villejuif
2025-08-04
Recruiting
dsm-firmenich Switzerland AG
Not applicable
236
Paris, Saint-Herblain
2025-08-01
Active, closed
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
NCT07044297Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
DrugMK-8527
Merck Sharp & Dohme LLC
Phase 3
4,390
Paris
2025-07-31
Active, closed
Boston Scientific Corporation
Observational
550
Clermont-Ferrand, Grenoble, Paris, Saint-Denis, Saint-Priest-en-Jarez, Toulouse
2025-07-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
298
Brest, Lille, Paris
2025-07-30
Active, closed
Boehringer Ingelheim
Phase 1
16
Montpellier, Paris
2025-07-29
Recruiting
Free for Weaning ECMO vs Respiratory Driven Study
NCT06876415ARDS (Acute Respiratory Distress Syndrome)
Assistance Publique Hopitaux De Marseille
Not applicable
50
Lyon, Marseille, Nice, Paris
2025-07-29
Recruiting
Celgene
Phase 3
400
Pessac, Saint-Cloud, Montpellier, Nantes, Lille, Pierre-Bénite, Paris, Toulouse
2025-07-28
Recruiting
Immunomonitoring of Mold Invasive Infections
NCT06285188Invasive Fungal Disease, Mold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
Assistance Publique - Hôpitaux de Paris
Observational
20
Paris
2025-07-28
Recruiting
Kiniksa Pharmaceuticals International, plc
Phase 2/3
325
Montpellier, Paris, Pessac, Poitiers, Toulouse
2025-07-25
Recruiting
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
NCT06661655Metabolic Syndrome X, Fatty Liver, MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD
E-Scopics
Not applicable
120
Angers, Clichy, Paris
2025-07-24
Recruiting
AbbVie
Phase 1/2
325
Montpellier, Poitiers, Toulouse, Nantes, Paris
2025-07-23
Recruiting
Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)
NCT06670222Low-risk Myelodysplastic Syndromes
DrugArsenic Trioxide
Groupe Francophone des Myelodysplasies
Phase 1
24
Nice, Paris, Villejuif
2025-07-22
Active, closed
Lyv Healthcare
Not applicable
400
Aix-en-Provence, Caen, Rennes, Bordeaux, Le Chesnay, Le Mans, Lille, Paris
2025-07-21
Recruiting
Teleflex
Not applicable
150
Lyon, Essey-lès-Nancy, Saint-Laurent-du-Var, Paris
2025-07-18
Active, closed
BicycleTx Limited
Phase 2
73
Paris
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Angers, Bordeaux, Caen, Lyon, Marseille, Montpellier, Nantes, Paris
2025-07-17
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
DrugsUplizna·Inebilizumab·Blinatumomab
Amgen
Phase 2
220
Le Kremlin-Bicêtre, Lille, Lyon, Lyon Cédex 3, Marseille, Paris, Strasbourg, Toulouse
2025-07-16
Recruiting
Bristol-Myers Squibb
Phase 3
426
Toulouse, Villeurbanne, Lille, Limoges, Montpellier, Paris, Strasbourg
2025-07-16
Recruiting
Centre Hospitalier St Anne
Not applicable
600
Paris
2025-07-16
Recruiting
Takeda
Phase 3
347
Créteil, Bordeaux, Limoges, Montpellier, Nantes, Paris
2025-07-15
Recruiting
Fondation Hôpital Saint-Joseph
Observational
100
Paris
2025-07-15
Recruiting
Pfizer
Phase 3
300
Lille, Dijon, Paris
2025-07-14
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
Toulouse, Montpellier, Rennes, Strasbourg, Paris
2025-07-14
Recruiting
4TEEN4 Pharmaceuticals GmbH
Phase 1/2
90
Bobigny, Dijon, Lille, Limoges, Nancy, Paris
2025-07-13
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
846
Issy-les-Moulineaux, Ivry-sur-Seine, Paris
2025-07-09
Active, closed
Glycomine, Inc.
Phase 2/3
50
Paris
2025-07-09
Recruiting
Orvida Pharma (formerly Kamari Pharma)
Phase 1
64
Paris, Rennes
2025-07-08
Recruiting
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
NCT06890078Pneumocystis, Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris
Observational
240
Paris
2025-07-08
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2025-07-04
Recruiting
Radiation Free Study
NCT06549348Aortic Aneurysm
Philips Clinical & Medical Affairs Global
Not applicable
182
Paris
2025-07-03
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
242
Brest, Marseille, Paris
2025-07-03
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Chambray-lès-Tours, Créteil, Dijon, La Tronche, Marseille, Martinique, Montpellier, Paris
2025-07-02
Recruiting
Evaluation of Facial HA Dermal Fillers in Real-Life Conditions
NCT07255261Lips Enhancement, Perioral Wrinkles, Nasolabial Fold Wrinkles, Cheek Augmentation
Symatese
Not applicable
460
Arras, Lyon, Palaiseau, Paris, Saint-Maur-des-Fossés
2025-07-02
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
138
Paris
2025-07-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
180
Paris
2025-07-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
3,149
Lyon, Paris
2025-07-01
Not yet open
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
206
Besançon, La Tronche, Lille, Paris, Poitiers, Reims, Saint-Cloud, Saint-Etienne
2025-07
Not yet open
Toro Neurovascular, Inc.
Not applicable
15
Paris
2025-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
18
Paris
2025-06-30
Recruiting
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
NCT06615843Genital Diseases, Female, Ectopic Pregnancy, Uncertain Viability of Pregnancy, Abortion, Missed
Assistance Publique - Hôpitaux de Paris
Not applicable
200
Paris
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
147
Paris
2025-06-30
Recruiting
MedSIR
Phase 2
200
Caen, Lyon, Marseille, Paris, Saint-Priest-en-Jarez
2025-06-30
Active, closed
Azafaros B.V.
Phase 3
75
Paris
2025-06-30
Recruiting
Hoffmann-La Roche
Phase 3
75
Lille, Paris
2025-06-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
254
Paris
2025-06-27
Recruiting
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
NCT06711666Congenital Heart Disease, Cyanotic Congenital Heart Disease, d-Transposition of the Great Arteries, Hypoplastic Left Heart Syndrome
Institut National de la Santé Et de la Recherche Médicale, France
Observational
174
Marseille, Montpellier, Palavas-les-Flots, Paris, Pessac
2025-06-27
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 2
334
Clermont-Ferrand, Lyon, Marseille, Metz, Paris, Pierre-Bénite, Saint-Etienne
2025-06-26
By invitation
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
NCT07008469Myotonic Dystrophy Type 1, DM1, Myotonic Dystrophy, Myotonia
Avidity Biosciences, Inc.
Phase 3
199
Paris
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen
2025-06-26
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
182
Paris
2025-06-26
Recruiting
eleva GmbH
Phase 1
39
Paris, Toulouse
2025-06-26
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
14
Bordeaux, Lille, Marseille, Paris, Toulouse
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Saint-Priest-en-Jarez
2025-06-26
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice, Colmar, Paris
2025-06-25
Recruiting
Centre Hospitalier Universitaire de Besancon
Not applicable
120
Besançon, Chalon-sur-Saône, Grenoble, Mulhouse, Paris, Poitiers, Reims, Strasbourg
2025-06-25
Recruiting
INNODIA Family & Friends Early-Stage T1D Detection Protocol
NCT07118098Type 1 Diabetes (T1D), Pre Diabetes
INNODIA iVZW
Observational
30,000
Angers, Bobigny, Bondy, Corbeil-Essonnes, Lyon, Nice, Paris, Vandœuvre-lès-Nancy
2025-06-25
Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT07020221Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer, Colorectal Cancer, Solid Tumor, Adult
DrugsRepaglinide·VS-7375·Defactinib·Erbitux
Verastem, Inc.
Phase 1/2
616
Lyon, Marseille, Paris
2025-06-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
150
Paris
2025-06-24
Active, closed
Incyte Corporation
Phase 3
580
Bordeaux, Brest, Nantes, Nice, Paris
2025-06-23
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Bordeaux, Clermont-Ferrand, Lille, Marseille, Nice, Nîmes, Paris, Poitiers
2025-06-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
800
Paris
2025-06-23
Recruiting
Ventricular Arrhythmias in Acute Myocardial Infarction
NCT07517523Ventricular Arrhythmia, Acute Myocardial Infarction (AMI)
Poitiers University Hospital
Observational
500
Caen, Dijon, Grenoble, Paris, Pau, Poitiers, Saint-Etienne, Tours
2025-06-20
By invitation
BioMarin Pharmaceutical
Phase 3
140
Lyon, Marseille, Paris, Toulouse
2025-06-20
Active, closed
Calluna Pharma AS
Phase 2
150
Bobigny, Paris, Rennes, Toulouse, Tours
2025-06-20
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
7,500
Paris
2025-06-20
Recruiting
Step Pharma, SAS
Phase 2
50
Poitiers, Brest, Marseille, Nantes, Nice, Nîmes, Paris, Villejuif
2025-06-18
Recruiting
Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
NCT06486792Stroke, Ischemic Stroke, Cerebral Infarction, Atrial Fibrillation
DrugsDabigatran·Apixaban·Rivaroxaban·Aspirin
Assistance Publique - Hôpitaux de Paris
Phase 4
1,148
Paris
2025-06-18
By invitation
Can Cognitive Behavioural Therapy Help Incarcerated Men Quit Smoking? Efficacy and Predictors of Treatment Outcomes
NCT06873009Tobacco Use, Smoking Cessation, Cognitive Behavioral Therapy, Prisoners
Centre Hospitalier St Anne
Not applicable
202
Paris
2025-06-18
Active, closed
ANRS, Emerging Infectious Diseases
Phase 1/2
48
Caen, Clermont-Ferrand, Créteil, Lille, Nantes, Paris
2025-06-18
Active, closed
Prediction of Lung Transplant Outcome
NCT07356752Graft Dysfunction, Lung Transplantation, Chronic Lung Allograft Dysfunction (CLAD), Chronic Rejection of Lung Transplant
Hopital Foch
Not applicable
4,200
Paris, Strasbourg, Talence, Grenoble, Le Plessis-Robinson, Lyon, Nantes, Suresnes
2025-06-17
Recruiting
Evaluation of Rehabilitation Practices in the Intensive Care Unit
NCT06969443Invasive Mechanical Ventilation, Rehabilitation Exercise of ICU Patients
French Society for Intensive Care
Observational
1,000
Paris
2025-06-17
Active, closed
Arrowhead Pharmaceuticals
Phase 3
70
Paris
2025-06-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
400
Paris
2025-06-17
Active, closed
AbbVie
Phase 3
573
Nice, Montpellier, Créteil, St-Priest-en-Jarez, Paris
2025-06-17
Recruiting
Nantes University Hospital
Not applicable
362
Angers, Bordeaux, Grenoble, Lyon, Marseille, Nantes, Paris, Rennes
2025-06-17
Recruiting
Small Bowel Capsule Endoscopy in Lynch Syndrome
NCT07472686MMR Mutation, Small Bowel Adenoma, Small-bowel Adenocarcinoma, Lynch Syndrome
Assistance Publique - Hôpitaux de Paris
Observational
400
Paris
2025-06-16
Recruiting
Relay Therapeutics, Inc.
Phase 2
277
Paris
2025-06-13
Recruiting
Centre Hospitalier St Anne
Observational
50
Paris
2025-06-13
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
166
Caen, Dijon, Lille, Lyon, Marseille, Clichy, Paris, Villejuif
2025-06-12
Active, closed
Novartis Pharmaceuticals
Phase 1
57
Brest, Le Kremlin-Bicêtre, Paris
2025-06-12
Recruiting
Ferring Pharmaceuticals
Phase 1/2
20
Paris
2025-06-12
Recruiting
GlaxoSmithKline
Phase 1/2
346
Dijon, Marseille, Paris, Poitiers, Rennes, Villejuif
2025-06-11
Recruiting
BeOne Medicines
Phase 3
630
ClermontFerrand, Nantes, Paris, PierreBenite, Reims, Rennes Cedes, Rouen, Toulouse
2025-06-11
Recruiting
Long Term Follow-up of Cardiac Arrest Survivors Exposed to Ultra-rapid Cooling
NCT07028372Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, Post Cardiac Arrest Patient Who Was Treated by Hypothermia Protocol
Assistance Publique - Hôpitaux de Paris
Observational
12
Angers, Paris
2025-06-11
Recruiting
Institut Curie
Observational
500
Paris
2025-06-10
Recruiting
Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting
NCT07047053Vaccination Varicella-zoster Virus, Immune-mediated Systemic Inflammatory Diseases
Assistance Publique - Hôpitaux de Paris
Observational
50
Paris
2025-06-10
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Bron, Dijon, Marseille, Paris, Saint-Herblain
2025-06-10
Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1
DrugDel-brax
Avidity Biosciences, Inc.
Phase 3
200
Marseille, Montpellier, Nice, Paris
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Angers, Besançon, Caen, Le Mans, Marseille, Paris, Saint-Herblain, Strasbourg
2025-06-10
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
80
Paris
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Amiens, Créteil, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2025-06-09
Active, closed
Biogen
Phase 3
255
Montpellier, Paris
2025-06-09
Recruiting
Calico Life Sciences LLC
Phase 2
240
Lyon, Brest, Toulouse, Marseille, Paris
2025-06-09
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Lyon, Bordeaux, Toulon, Paris
2025-06-09
Recruiting
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
NCT04871191Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
DrugsTofacitinib·Tocilizumab·Rituximab
Assistance Publique - Hôpitaux de Paris
Phase 3
42
Paris
2025-06-06
Recruiting
Wladimir MAUHIN, Dr
Not applicable
200
Paris
2025-06-05
Recruiting
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
NCT06797999Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
Adcendo ApS
Phase 1/2
270
Paris, Lyon
2025-06-05
Recruiting
GlaxoSmithKline
Phase 2
80
Le Mans, Nice, Paris, Poitiers, Toulouse
2025-06-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
924
Paris
2025-06-04
Recruiting
Hôpital Privé de la Baie
Not applicable
58
Avranches, Paris, St-Malo
2025-06-04
Active, closed
Incyte Corporation
Phase 3
9
Amiens, Caen, Lille, Marseille, Nantes, Nice, Paris, Pessac
2025-06-04
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Angers, Clermont-Ferrand, Lille, Marseille, Montpellier, Nice, Paris, Pierre-Bénite
2025-06-04
Active, closed
Stoke Therapeutics, Inc
Phase 3
170
Marseille, Paris
2025-06-04
Recruiting
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
NCT06891443Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Sensation Disorders
DrugSepofarsen
Laboratoires Thea
Phase 3
32
Paris
2025-06-04
Recruiting
University Hospital, Grenoble
Observational
35
Lyon, Pierre-Bénite, Strasbourg, La Tronche, Montpellier, Toulouse, Paris
2025-06-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
500
Paris
2025-06-02
Not yet open
Institut Pasteur
Not applicable
110
Marseille, Paris
2025-06
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
30
Paris
2025-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
500
Paris, Toulouse
2025-05-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2
160
Nice, Paris, Villejuif
2025-05-29
Recruiting
Swedish Orphan Biovitrum
Phase 2
156
Lille, Paris, Pierre-Bénite, Poitiers, Toulouse
2025-05-28
Recruiting
AbbVie
Phase 2
110
Caen, Plérin, Vandœuvre-lès-Nancy, Lille, Nice, Pierre-Bénite, La Roche-sur-Yon, Paris
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Bordeaux, Marseille, Nantes, Lyon, Paris
2025-05-26
Recruiting
Antagonization of Heparin With Protamine Sulfate After TAVI
NCT06215378Aortic Valve Stenosis, Heart Valve Diseases
Assistance Publique - Hôpitaux de Paris
Phase 3
940
Paris
2025-05-25
Recruiting
Eikon Therapeutics
Phase 2/3
740
Pierre-Bénite, Boulogne, La Tronche, Lille, Marseille, Nice, Paris, Saint-Herblain
2025-05-22
Recruiting
Institut Pasteur
Phase 3
92
Marseille, Paris, Rouen
2025-05-22
Recruiting
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
NCT06865651Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 2
44
Grenoble, Montpellier, Paris, Pierre-Bénite
2025-05-22
Recruiting
Effectiveness of PKP vs DSAEK in Terms of 2-year Postoperative Visual Acuity in Advanced BPK
NCT06818747Bullous Pseudophakic Keratopathy, Penetrating Keratoplasty
Centre Hospitalier Régional Metz-Thionville
Not applicable
334
Besançon, Bordeaux, Brest, Metz, Nantes, Paris, Saint-Etienne, Strasbourg
2025-05-21
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Bordeaux, Marseille, Montpellier, Nantes, Paris, Rennes, Rouen
2025-05-21
Recruiting
Clinique Victor Hugo
Not applicable
210
Paris, Saint-Grégoire
2025-05-19
Active, closed
UroMems SAS
Not applicable
140
Lille, Marseille, Nantes, Paris, Pierre-Bénite, Rennes, Rouen, Suresnes
2025-05-19
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Créteil, La Rochelle, La Tronche, Montpellier, Nantes, Paris, Toulouse
2025-05-19
Recruiting
SecuraBio
Phase 3
124
Rouen, Villejuif, Caen, Clermont-Ferrand, Montpellier, Nantes, Paris, Pessac
2025-05-19
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Brest, Lille, Lorient, Paris, Pierre-Bénite, Reims, Rouen
2025-05-16
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4
50
Angers, Dijon, Lyon, Paris, Toulouse, Tours, Villejuif
2025-05-16
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Lille, Nancy, Paris, Rouen, Toulouse, Tours
2025-05-15
Recruiting
Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
NCT06457386Staphylococcus Aureus, Bacteremia, Infective Endocarditis
Assistance Publique - Hôpitaux de Paris
Not applicable
700
Paris
2025-05-14
Active, closed
Eli Lilly and Company
Phase 3
465
Bois-Guillaume, Corbeil-Essonnes, Grenoble, Le Creusot, Marseille, Paris, Toulouse, Vénissieux
2025-05-12
Recruiting
ANRS, Emerging Infectious Diseases
Phase 1/2
238
Dijon, Lyon, Paris, Saint-Priest-en-Jarez, Tours
2025-05-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
90
Paris
2025-05-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
80
Paris
2025-05-06
Recruiting
Takeda
Phase 3
225
Nice, Paris, Poitiers, Toulouse
2025-05-06
Recruiting
Takeda
Phase 2
88
Montpellier, Paris
2025-05-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2/3
1,200
Paris
2025-05-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
336
Paris
2025-05-05
Recruiting
National Multicentre Study of the Natural History of Acid Sphingo-myelinase Deficiency in Adults and Children
NCT06985212Acid Sphingomyelinase Deficiency (ASMD), Niemann Pick Disease
Wladimir MAUHIN, Dr
Observational
200
Paris
2025-05-02
Recruiting
AstraZeneca
Phase 1
72
Bordeaux, Montpellier, Nancy, Paris, Strasbourg, Toulouse
2025-05-01
By invitation
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients
NCT07070284Severe Community-Acquired Pneumonia (sCAP), Elderly Infection, Community-Acquired Infections, Health Care Quality, Access, and Evaluation
Joan Sabater-Riera
Observational
500
Alès, Chamonix, Contamine-sur-Arve, Melun, Paris
2025-05-01
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329Progressive Pulmonary Fibrosis, Interstitial Lung Disease
University of Massachusetts, Worcester
Observational
500
Paris, Rennes
2025-05-01
Not yet open
Analysis of Risk Factors for Hearing Loss in Survivors of Cancer Occurred During Childhood, Adolescence or Young Adulthood
NCT06957132Ototoxicity, Drug-Induced, Ototoxicity, Radiation-Induced, Pediatric Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
500
Paris, Villejuif
2025-05
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,000
Paris
2025-04-30
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Béziers, Cholet, Grenoble, Lille, Montpellier, Paris, Pessac, Poitiers
2025-04-30
Recruiting
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Phase 2
408
Paris
2025-04-30
Active, closed
Hoffmann-La Roche
Observational
44
Lille, Paris
2025-04-29
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Phase 3
128
Bordeaux, Garches, Lille, Lyon, Nice, Paris, Strasbourg, Toulouse
2025-04-29
Recruiting
Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke
NCT06951035Chonic Stroke Patients With Motor Impairment of Upper Limb
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
50
Paris
2025-04-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Annecy, Clermont-Ferrand, Lyon, Paris
2025-04-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
90
Paris
2025-04-24
Recruiting
AbbVie
Phase 2
390
Lille, Poitiers, Nantes, Paris
2025-04-24
Recruiting
Société Française d'Anesthésie et de Réanimation
Observational
1,000
Paris
2025-04-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
327
Paris
2025-04-23
By invitation
QED Therapeutics, a BridgeBio company
Phase 2/3
24
Bron, Paris, Toulouse
2025-04-22
Recruiting
Institut Pasteur
Not applicable
75
Paris
2025-04-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2025-04-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
304
Paris
2025-04-16
Not yet open
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
NCT06907563Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Steatotic Liver Disease of Mixed Origin (MetALD), ALD - Alcoholic Liver Disease
Universität des Saarlandes
Observational
30,000
Paris
2025-04-15
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Phase 1
5
Paris
2025-04-15
Recruiting
Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes
NCT06820866Idiopathic Nephrotic Syndrome (INS)
Assistance Publique - Hôpitaux de Paris
Observational
265
Paris
2025-04-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
2,000
Paris
2025-04-12
Recruiting
Clinique Bizet
Not applicable
50
Paris
2025-04-11
Active, closed
ASCEND CSP IDE Study
NCT06830746Heart Failure, Ventricular Arrythmia
Abbott Medical Devices
Not applicable
414
Rennes, Chambray-lès-Tours, Paris
2025-04-11
Recruiting
The 3D Stent Study
NCT06898021Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)
CoreAalst BV
Observational
200
Paris
2025-04-11
Recruiting
Effects of Nasal Airflow on Sleep in Tracheotomized Patients
NCT06547463Patients With Prolonged Weaning
Assistance Publique - Hôpitaux de Paris
Observational
24
Paris
2025-04-10
Recruiting
UNICANCER
Phase 3
700
Brest, Dijon, Paris, Saint-Etienne, Villejuif
2025-04-10
Recruiting
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002Immunology, Allergy, Genetic Diseases, Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France
Observational
500
Lille, Lyon, Montpellier, Paris, Tours
2025-04-09
Recruiting
Hoffmann-La Roche
Phase 3
450
Angers, Lille, Montpellier, Paris, Plérin, Poitiers, Rennes, Rouen
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Lille, Bordeaux, Pierre-Bénite, Caen, Plérin, Toulouse, Chambray-lès-Tours, Paris
2025-04-09
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Marseille, Pessac, Paris
2025-04-09
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
120
Paris
2025-04-09
Recruiting
Vifor Pharma, Inc.
Phase 2
36
Montpellier, Paris, Toulouse
2025-04-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
491
Limoges, Paris, Villejuif
2025-04-04
Recruiting
Gilead Sciences
Phase 3
695
Angers, Créteil, La Tronche, Lyon, Marseille, Paris, Pessac, Rennes
2025-04-04
Active, closed
Merck Sharp & Dohme LLC
Phase 2
160
Caen, Montpellier, Villejuif, Paris
2025-04-01
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
806
Marseille, Paris
2025-04-01
Not yet open
ANRS, Emerging Infectious Diseases
Not applicable
34
Clamart, Le Kremlin-Bicêtre, Paris
2025-04-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
50
Paris
2025-04-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
110
Paris
2025-04-01
Recruiting
Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment
NCT06858527Attention Deficit Hyperactivity Disorder (ADHD), Substance-related Disorder
Assistance Publique - Hôpitaux de Paris
Not applicable
132
Paris
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Nice, Paris
2025-04-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
264
Bobigny, Colombes, Créteil, Marseille, Nantes, Orléans, Paris, Poitiers
2025-04
Recruiting
Nimbus Wadjet, Inc.
Phase 1/2
134
Paris, Poitiers
2025-03-31
Recruiting
Laboratoires URGO
Not applicable
210
Paris, Lyon
2025-03-29
Recruiting
Prescient Therapeutics, Ltd.
Phase 2
115
Bordeaux, Lyon, Paris
2025-03-28
Recruiting
UNICANCER
Phase 2
40
Brest, Nice, Paris, Poitiers, Saint-Priest-en-Jarez, Vandœuvre-lès-Nancy
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Bron, La Tronche, Lyon Cedex08, Marseille, Nice, Paris, Pessac, Poitiers
2025-03-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
108
Paris
2025-03-27
Recruiting
AstraZeneca
Phase 3
600
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Montpellier, Nice, Paris
2025-03-27
Recruiting
Hôpital Armand Trousseau
Observational
500
Paris
2025-03-27
Not yet open
Impact of Vestibular Function on Deaf Infants' Activities of Daily Living
NCT06909266Vestibular Dysfunction, Hearing Loss, Motor Development
Assistance Publique - Hôpitaux de Paris
Observational
105
Paris
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
510
Avignon, Brest, Dijon, Montpellier, Paris, Poitiers, Rennes, Strasbourg
2025-03-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
280
Paris
2025-03-26
Recruiting
MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS
NCT06660108Developmental Language Disorder
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
50
Corbeil-Essonnes, Garches, Paris
2025-03-25
Recruiting
AstraZeneca
Phase 3
990
Brest, Lyon, Marseille, Montpellier, Paris, Pessac, Saint-Herblain
2025-03-25
Recruiting
Craniopharyngioma and Pregnancies
NCT06801756Craniopharyngioma
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2025-03-24
Recruiting
Institut Pasteur
Not applicable
270
Paris
2025-03-24
Recruiting
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Not applicable
200
Paris, Saint-Denis
2025-03-21
Recruiting
Prevalence, Determinants and Consequences of Dyspnea During Weaning in Critically Ill Obese Patients
NCT06867354Obesity, Obesity With Complications, Weaning From Mechanical Ventilation in Care Unit, Dyspnea
Assistance Publique - Hôpitaux de Paris
Observational
80
Paris
2025-03-21
Recruiting
Metabolic Fluid Responsiveness in Children
NCT07255469Circulatory Failure / Shock State, Fluid Therapy
University Hospital, Bordeaux
Observational
110
Bron, Lille, Marseille, Nantes, Paris, Pessac, Toulouse, Saint-Denis
2025-03-21
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
La Tronche, Lille, Marseille, Nice, Paris
2025-03-20
Recruiting
ANRS, Emerging Infectious Diseases
Not applicable
100
Lyon, Paris
2025-03-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
20
Gif-sur-Yvette, Paris
2025-03-19
Recruiting
Daiichi Sankyo
Phase 3
582
Bordeaux, Dijon, Lille, Lyon, Montpellier, Nantes, Paris, Rennes
2025-03-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
3,000
Paris
2025-03-19
Recruiting
Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
NCT06582121Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
Assistance Publique - Hôpitaux de Paris
Not applicable
457
Clermont-Ferrand, Lille, Lyon, Nantes, Nîmes, Paris
2025-03-18
Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
NCT06376162Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia, Relapsed/Refractory NPM1-m Acute Leukemia
DrugsZiftomenib·Cytarabine·Fludarabine
PedAL BCU, LLC
Phase 1
20
Nantes, Paris
2025-03-18
Active, closed
Hedia ApS
Not applicable
154
Angers, Lyon, Nantes, Nîmes, Paris, Poitiers
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Lyon, Limoges, Montpellier, Saint-Herblain, Reims, Rouen, Toulon, Paris
2025-03-16
Not yet open
University Hospital, Clermont-Ferrand
Not applicable
30
Clermont-Ferrand, Paris, Saint-Etienne
2025-03-15
Active, closed
Ipsen
Phase 1/2
42
Lyon, Paris, Villejuif
2025-03-14
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Bordeaux, Grenoble, Lille, Lyon, Montpellier, Nancy, Paris, Perpignan
2025-03-14
Active, closed
Hoffmann-La Roche
Phase 4
274
Bordeaux, Lyon, Paris, Saint-Cyr-sur-Loire, Saint-Jean
2025-03-14
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Lille, Nantes, Pierre-Bénite, Créteil, Paris
2025-03-12
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Dijon, Bordeaux, Rouen, Suresnes, Paris
2025-03-11
Recruiting
UCB Biopharma SRL
Phase 3
40
Indre-et-Loire, Le Kremlin-Bicêtre, Paris, Poitiers
2025-03-11
Recruiting
Societe Francaise de Rhumatologie
Not applicable
112
Créteil, Dijon, Grenoble, Lomme, Marseille, Nice, Nîmes, Paris
2025-03-10
Recruiting
Capsaicin in Digital Osteoarthritis Versus Control
NCT06444919Osteoarthritis Hand, Neuropathic Pain
DrugCapsaicin
University Hospital, Clermont-Ferrand
Phase 4
120
Clermont-Ferrand, Lyon, Paris, Saint-Etienne
2025-03-07
Recruiting
Phenox GmbH
Observational
200
Amiens, Bordeaux, Bron, Clermont-Ferrand, Le Kremlin-Bicêtre, Limoges, Paris, Reims
2025-03-07
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
DrugsCobolimab·Dostarlimab
GlaxoSmithKline
Phase 1/2
83
Bordeaux, Lyon, Paris, Strasbourg, Villejuif
2025-03-06
Recruiting
AbbVie
Phase 1/2
252
Bordeaux, Saint-Herblain, Montpellier, Nice, Villejuif, Paris
2025-03-06
Recruiting
Emobot
Not applicable
104
Agen, Caen, Laxou, Maxéville, Nantes, Paris, Reims, Rennes
2025-03-05
Recruiting
Evaluation of the HPA Axis in Patients With Vasoplegic Syndrome After Cardiac Surgery
NCT06371976Vasoplegic Syndrome in Adult Cardiac Surgery
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2025-03-05
Recruiting
Refractory Cardiac Arrest Treated On Field By ECMO
NCT06397417Out-of-Hospital Cardiac Arrest, Extracorporeal Cardiopulmonary Resuscitation
Assistance Publique - Hôpitaux de Paris
Observational
840
Paris
2025-03-05
Recruiting
Tyra Biosciences, Inc
Phase 2
92
Paris
2025-03-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
20
Paris
2025-03-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,322
Paris
2025-03-04
Recruiting
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Observational
80
Paris
2025-03-03
Not yet open
Fondation Hôpital Saint-Joseph
Observational
500
Paris
2025-03-01
Recruiting
Fondation Hôpital Saint-Joseph
Observational
200
Paris
2025-03-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
160
Paris
2025-03-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
442
Paris
2025-03
Not yet open
Institut Pasteur
Not applicable
50
Paris
2025-03
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
125
Paris
2025-03
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
60
Paris
2025-03
Not yet open
ORIXHA
Not applicable
24
Paris
2025-03
Not yet open
CNGE Conseil
Observational
1,500
Paris
2025-02-28
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
DrugsMomelotinib·Reblozyl·Luspatercept
GlaxoSmithKline
Phase 2
68
Angers, Brest, Lyon, Nice, Nîmes, Paris, Poitiers
2025-02-28
Active, closed
Pierre Fabre Dermo Cosmetique
Not applicable
102
Paris
2025-02-28
Recruiting
Nantes University Hospital
Observational
450
Nantes, Bordeaux, Clamart, Le Plessis-Robinson, Marseille, Paris, Toulouse, Tours
2025-02-28
Recruiting
Factors Influencing Corneal Donation in Palliative Care Unit
NCT07868198Corneal Transplantation, Corneal Diseases, Corneal Donation
Groupe Hospitalier Diaconesses Croix Saint-Simon
Observational
150
Paris
2025-02-27
Recruiting
Summit Therapeutics
Phase 3
780
Nantes, Avignon, Brest, Créteil, Lille, Lyon, Marseille, Paris
2025-02-27
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
NCT06823167Solid Malignancies, Hematologic Malignancies
Immunome, Inc.
Phase 1
190
Lyon, Paris, Villejuif
2025-02-26
Recruiting
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
NCT06435468Systemic Lupus, Autoimmune Diseases, Autoinflammatory Disease, Genetic Disease
Hospices Civils de Lyon
Not applicable
400
Bron, Lille, Nice, Paris, Saint-Etienne, Grenoble, Rouen, Strasbourg
2025-02-26
Recruiting
Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis
NCT06354322AA Amyloidosis, Autoinflammatory Disease
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2025-02-26
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
300
Boulogne-Billancourt, Lille, Marseille, Nantes, Paris
2025-02-26
Recruiting
Amgen
Phase 3
844
Bordeaux, Brest, Mulhouse, Paris, Strasbourg
2025-02-25
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
180
Paris
2025-02-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
60
Paris
2025-02-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
180
Paris
2025-02-24
Rows per page Showing 501–1000 of 2821
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,821 of those studies with a site in Paris.

How many clinical trials are recruiting in Paris?

1,622 of the 2,821 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 321 have not yet opened recruitment, 831 are active but closed to new participants, and 47 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.